KAL1 Antikörper (AA 200-300)
Kurzübersicht für KAL1 Antikörper (AA 200-300) (ABIN7268068)
Target
Alle KAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 200-300
-
Verwendungszweck
- KAL1 Rabbit pAb
-
Sequenz
- LEVKWSSKFN ISIEPVIYVV QRRWNYGIHP SEDDATHWQT VAQTTDERVQ LTDIRPSRWY QFRVAAVNVH GTRGFTAPSK HFRSSKDPSA PPAPANLRLA N
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthetic peptide corresponding to a sequence within amino acids 200-300 of human KAL1 (NP_000207.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Andere Bezeichnung
- KAL1
-
Hintergrund
- Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity.,ANOS1,ADMLX,HH1,HHA,KAL,KAL1,KALIG-1,KMS,WFDC19,anosmin-1,Cell Biology & Developmental Biology,Cell Adhesion,Endocrine & Metabolism,Neuroscience,KAL1
-
Molekulargewicht
- 76kDa
-
Gen-ID
- 3730
-
UniProt
- P23352
Target
-